Important Dates

As of OCTOBER 15, 2019 11:59 PM ET (North America) the ISHLT2020 Submission Site is CLOSED.
 

DECEMBER 10, 2019
Abstract Status Notifications

December 10
 

DECEMBER 30, 2019
Abstract Presentation Notifications

December 30

Thank You for Submitting Your Best Science for ISHLT2020!

Stephan EnsmingerOn behalf of Stuart Sweet, MD, PhD, President of the International Society for Heart and Lung Transplantation, the ISHLT Board of Directors, and the ISHLT2020 Scientific Program Committee, thank you for submitting your research and expertise to be shared with peers in the Society’s 40th Anniversary Meeting and Scientific Sessions to be held April 22-25, 2019, in Montreal, Canada.

We look forward to building on the tremendous success of ISHLT2019 in Orlando, Florida, by continuing to present some of the most ground-breaking investigative studies in the treatment of advanced heart and lung disease. The ISHLT welcomes submissions from all specialists engaged in treating advanced heart and lung disease, particularly those working on novel therapies.   Read More →
 
Research Abstracts Junior Faculty Clinical Case Reports Late Breaking Clinical Science
Review and Process Submission Policies FAQ
 

Submission Instructions

There are THREE areas in which to submit an abstract:
 
  1. RESEARCH (view format and subject categories)
  2. JUNIOR FACULTY CLINICAL CASE REPORTS (view format, categories and restrictions)
  3. LATE BREAKING CLINICAL SCIENCE (learn more)

Each abstract may be submitted in only ONE of these areas. Submission of the same abstract into different categories is not permitted. Submission of one study as several different abstracts is not permitted. If the abstracts in question are not distinct enough to be considered separate studies, or if the same abstract is submitted into multiple categories, all versions may be rejected.

Please review the ISHLT Abstract Submission Policies prior to submitting your abstract.
For questions regarding tables, images and character limits, check out our Abstract FAQ.